Youwei Bi

FDA Approval Summary: Sotorasib for <i>KRAS G12C</i> -Mutated Metastatic NSCLC

Erica C. Nakajima, Nicole Drezner, Xiaoxue Li et al. · Clinical Cancer Research · 2021 · 305 citations · Full text

Medicine, Oncology, Pharmacology +13

Acute Exacerbation and Decline in Forced Vital Capacity Are Associated with Increased Mortality in Idiopathic Pulmonary Fibrosis

Miya Paterniti, Youwei Bi, Dinko Rekić et al. · Annals of the American Thoracic Society · 2017 · 196 citations

Medicine, Pharmacology, Pharmacotherapy +13

FDA Approval: Ribociclib for the Treatment of Postmenopausal Women with Hormone Receptor–Positive, HER2-Negative Advanced or Metastatic Breast Cancer

Anand Shah, Erik Bloomquist, Shenghui Tang et al. · Clinical Cancer Research · 2018 · 111 citations

Medicine, Oncology, Pharmacology +15

FDA Approval Summary: Pralsetinib for the Treatment of Lung and Thyroid Cancers With <i>RET</i> Gene Mutations or Fusions

Janice Kim, Diana Bradford, Erin Larkins et al. · Clinical Cancer Research · 2021 · 100 citations

Medicine, Molecular Medicine, Oncology +13

FDA Approval Summary: Selpercatinib for the Treatment of Advanced <i>RET</i> Fusion-Positive Solid Tumors

Elizabeth S. Duke, Diana Bradford, Michelle Marcovitz et al. · Clinical Cancer Research · 2023 · 82 citations · Full text

Medicine, Oncology, Molecular Oncology +13